Sera Prognostics and Newborn Foundation Partner to Reduce Risks Associated with Preterm Birth and Improve Health Equity Through the “Every Mother, Every Baby” Project May 5, 2022-Sera Prognostics
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting March 18, 2022-Sera Prognostics
Sera Prognostics Announces Collaboration to Help Underserved Communities Make Informed Decision about Prenatal Health November 4, 2021-Sera Prognostics
Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit September 15, 2021-Sera Prognostics
Sera Prognostics’ PreTRM® Test and Treat Strategy Benefits Demonstrated by Results of Prospective, Randomized Controlled Intervention Trial Evaluating Clinical Utility August 17, 2021-Sera Prognostics
Sera Prognostics and Anthem, Inc. Announce Commercial Partnership Leveraging Innovative Biomarker Test to Reduce Risk of Preterm Birth May 19, 2021-Sera Prognostics
